<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02151045</url>
  </required_header>
  <id_info>
    <org_study_id>8708</org_study_id>
    <nct_id>NCT02151045</nct_id>
  </id_info>
  <brief_title>Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica</brief_title>
  <acronym>EPI-AMELIE</acronym>
  <official_title>Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica - Controlled Randomized Trial With Double Blind Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In discal sciatica, after failure of medical treatment, the investigators propose frequently
      a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently,
      some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of
      indications of this type of infiltration. An alternative would be to propose a lateral
      epidural infiltration on contact with conflict.The objective of this study is to compare, in
      112 patients with a less than 6 months discal sciatica, the efficacy on pain of a non target
      posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control
      versus an epidural infiltration of the same corticoid done in lateral on contact of disco
      radicular conflict on scan control.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain evolution on analogic visual scale (EVA) ay Day 30</measure>
    <time_frame>at Day 30 after infiltration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain evolution on analogic visual scal (EVA) at Day 7</measure>
    <time_frame>at day 7 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain evolution on analogic visual scal (EVA) at month 3</measure>
    <time_frame>at month 3 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain evolution on analogic visual scal (EVA) at month 6</measure>
    <time_frame>at month 6 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain evolution on analogic visual scal (EVA) at month 12</measure>
    <time_frame>at month 12 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drug consumption at day 7</measure>
    <time_frame>at day 7 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drug consumption at month 3</measure>
    <time_frame>at month 3 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drug consumption at month 6</measure>
    <time_frame>at month 6 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drug consumption at month 12</measure>
    <time_frame>at month 12 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional handicap at Day 7</measure>
    <time_frame>at day 7 after infiltration</time_frame>
    <description>functional handicap is assessed by auto-questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional handicap at month 3</measure>
    <time_frame>at month 3 after infiltration</time_frame>
    <description>functional handicap is assessed by auto-questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional handicap at month 6</measure>
    <time_frame>at month 6 after infiltration</time_frame>
    <description>functional handicap is assessed by auto-questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional handicap at month 12</measure>
    <time_frame>at month 12 after infiltration</time_frame>
    <description>functional handicap is assessed by auto-questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>professional activity recovery at Day 7</measure>
    <time_frame>at day 7 after infiltration</time_frame>
    <description>professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>professional activity recovery at month 3</measure>
    <time_frame>at month 3 after infiltration</time_frame>
    <description>professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>professional activity recovery at month 6</measure>
    <time_frame>at month 6 after infiltration</time_frame>
    <description>professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>professional activity recovery at month 12</measure>
    <time_frame>at month 12 after infiltration</time_frame>
    <description>professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>new epidural infiltration or surgery of discal hernia at Day 7</measure>
    <time_frame>at day 7 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>new epidural infiltration or surgery of discal hernia at month 3</measure>
    <time_frame>at month 3 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>new epidural infiltration or surgery of discal hernia at month 6</measure>
    <time_frame>at month 6 after infiltration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>new epidural infiltration or surgery of discal hernia at month 12</measure>
    <time_frame>at month 12 after infiltration</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Discal Sciatica</condition>
  <arm_group>
    <arm_group_label>Non target epidural infiltration at L3-L4 stage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this control arm, there are patients with a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control.
These patients must have a discal hernia confirmed by scanner or RMI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural infiltration on contact of disco radicular conflict</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this experimental arm, there are patients with an epidural infiltration of corticoids done in lateral on contact of disco radicular conflict on scan control.
These patients must have a discal hernia confirmed by scanner or RMI</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non target epidural infiltration done at L3-L4 stage</intervention_name>
    <description>For patients included in control arm, a non target posterior epidural space infiltration of corticoids will be done at L3-L4 stage on scan control</description>
    <arm_group_label>Non target epidural infiltration at L3-L4 stage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural infiltration on contact of disco radicular conflict</intervention_name>
    <description>For patients included in experimental arm, an epidural infiltration of corticoids will be done in lateral on contact of disco radicular conflict on scan control.</description>
    <arm_group_label>Epidural infiltration on contact of disco radicular conflict</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Aged from 18 to 65 years

          -  Affiliated or benefit from an insurance regimen

          -  Patient with a sciatic answering to the definition

          -  Discal sciatica more than 15 days and less than 6 months

          -  Discal hernia (scan or RMI)

          -  Negative BHCG and normal coagulation parameters

        Exclusion Criteria:

          -  History of lumbar surgery

          -  Spinal infiltration of corticoids in 30 days before inclusion

          -  Iode allergy

          -  Anticoagulation therapy, unbalanced type 2 diabetes, instable HTA

          -  Motor loss &lt; 4 (muscular testing)

          -  Sphincter disorder (cauda equida syndrome)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric ET THOMAS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric ET THOMAS, MD</last_name>
    <phone>+33 4 67 33 86 40</phone>
    <email>e-thomas@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Montpellier - Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric ET THOMAS, MD</last_name>
      <phone>+33 4 67 33 86 40</phone>
      <email>e-thomas@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Eric ET THOMAS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marlène MG GENTY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine CC CYTEVAL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle IT TAVARES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yann YT THOUVENIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Carémeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile CG GAUJOUX-VIALA, MD</last_name>
      <phone>+33 4 66 68 31 20</phone>
      <email>cecilegaujouxviala@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile CG GAUJOUX-VIALA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominique DB BLIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2014</study_first_submitted>
  <study_first_submitted_qc>May 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2014</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epidural infiltration of Corticoids</keyword>
  <keyword>L3-L4 stage</keyword>
  <keyword>On contact of disco radicular conflict</keyword>
  <keyword>Scan control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sciatica</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cortivazol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

